Fundraising FoxResonant Therapeutics
Santa Barbara, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Resonant Therapeutics
Sign up to see every warm intro you have to Resonant Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Resonant Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JK
John K. WestwickChief Executive Officer & President
Board
DW
Dan WatkinsSecretary
Investors · 1
Mercury FundreportedHouston · $250K – $4M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5.1M disclosed across 3 rounds · 2015–2021
▶$2.5MraisedOct 2021 · 16 investors · BiotechnologyRule 506(b)
▶$2.5MraisedOct 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dan WatkinsDirector
- John K. WestwickExecutive Officer, Director
- Offering amount
- $4.1M
- Amount sold
- $2.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedAug 2017 · 3 investors · BiotechnologyRule 506(b)
▶$1.4MraisedAug 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dan WatkinsExecutive Officer, Director
- John K. WestwickExecutive Officer, Director
- Offering amount
- $2.6M
- Amount sold
- $1.4M
- Minimum investment
- $25K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.2MraisedOct 2015 · 3 investors · OtherRule 506(b)
▶$1.2MraisedOct 2015 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dan WatkinsExecutive Officer, Director
- John K. WestwickExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.2M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Resonant Therapeutics's investors?
- Resonant Therapeutics's investors include Mercury Fund.
- How much funding has Resonant Therapeutics raised?
- Resonant Therapeutics has disclosed $5.1M raised across 3 rounds.
- Where is Resonant Therapeutics headquartered?
- Resonant Therapeutics is headquartered in Santa Barbara, US.